Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
$1.41
-9.6%
$1.75
$0.88
▼
$2.34
$167.69M0.88776,849 shs3.59 million shs
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
$12.66
+0.4%
$13.28
$12.42
▼
$15.68
$134.40M0.840,553 shs22,603 shs
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
-6.02%-9.83%-27.44%+48.57%+45.79%
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
-0.24%-2.63%-6.84%-6.81%-18.85%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
$1.41
-9.6%
$1.75
$0.88
▼
$2.34
$167.69M0.88776,849 shs3.59 million shs
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
$12.66
+0.4%
$13.28
$12.42
▼
$15.68
$134.40M0.840,553 shs22,603 shs
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
-6.02%-9.83%-27.44%+48.57%+45.79%
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
-0.24%-2.63%-6.84%-6.81%-18.85%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
2.50
Moderate Buy$10.00609.22% Upside
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest CRDL, SPE, ACSO, and TRCS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/23/2026
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
Reiterated RatingBuy$9.00
9/21/2026
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
Reiterated RatingSell (D-)
8/26/2026
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
Initiated CoverageBuy$11.00
8/17/2026
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
Boost Price TargetBuy$8.00 ➝ $10.00
7/14/2026
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
Reiterated RatingBuy
(Data available from 10/2/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
N/AN/AN/AN/A$0.11 per shareN/A
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
-$24.20M-$0.25N/AN/AN/AN/A-180.44%-140.28%11/12/2026 (Estimated)
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest CRDL, SPE, ACSO, and TRCS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
-$0.09-$0.04+$0.05-$0.04N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
N/AN/AN/AN/AN/A
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
$1.5212.01%N/AN/AN/A

Latest CRDL, SPE, ACSO, and TRCS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/28/2026
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
monthly$0.108710.14%12/22/202612/22/202612/31/2026
9/28/2026
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
monthly$0.108710.14%11/17/202611/17/202611/30/2026
9/28/2026
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
monthly$0.108710.14%10/20/202610/20/202610/30/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
N/A
5.55
5.55
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
12.49%
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
35.60%

Insider Ownership

CompanyInsider Ownership
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
5.25%
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
1.13%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
18118.93 million110.08 millionNot Optionable
Special Opportunities Fund, Inc. stock logo
SPE
Special Opportunities Fund
N/A10.62 million10.50 millionNot Optionable

Recent News About These Companies

Healthcare Special Opportunities Fund Announces Final Distribution
Special Opportunities Fund, Inc. (SPE) To Go Ex-Dividend on December 22nd
Special Opportunities Fund Inc's Dividend Analysis
Special Opportunities Fund Inc
SPE.PR.C Stock Price

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cardiol Therapeutics stock logo

Cardiol Therapeutics NASDAQ:CRDL

$1.41 -0.15 (-9.62%)
Closing price 04:00 PM Eastern
Extended Trading
$1.40 -0.01 (-0.71%)
As of 06:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.

Special Opportunities Fund stock logo

Special Opportunities Fund NYSE:SPE

$12.66 +0.05 (+0.36%)
Closing price 03:57 PM Eastern
Extended Trading
$12.66 0.00 (0.00%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Special Opportunities Fund, Inc. is a close-ended balanced fund of funds launched and managed by Bulldog Investors, LLC. It invests in close-ended funds investing in public equity and fixed income markets. The fund employs a combination of value, opportunistic and special situations strategies to make its investments. It benchmarks the performance of its portfolio against the S&P 500 Index. The fund was previously known as Insured Municipal Income Fund, Inc. Special Opportunities Fund, Inc. was formed on February 18, 1993 and is domiciled in the United States.